Sort
15,842 grants matching “pancreatic cancer”
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer
$1,116,803Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
UCLA Center for Excellence in Pancreatic Diseases
$1,115,611Vay Liang W. Go · University Of California Los Angeles · P01 · FY2009 · AT
UCLA Center for Excellence in Pancreatic Diseases
$1,115,611Vay Liang W. Go · University Of California Los Angeles · P01 · FY2008 · AT
Cellular In vivo Imaging
$1,115,004Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Overhauser Enhanced Magnetic Resonance Imaging (OMRI)
$1,113,905Murali Cherukuri · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Molecular Pathogenesis of Digestive Diseases
$1,113,555Harry Bernard Greenberg · Stanford University · P30 · FY2006 · DK
A novel monobody-drug conjugate to treat mutant KRas pancreatic cancer.
$1,113,257Craig Patrick Ramirez · Tezcat Laboratories Llc · R44 · FY2025 · CA
Implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial
$1,111,364William Andrew Daunch · Focal Medical, Inc. · R44 · FY2018 · CA
Genetic Epidemiology of Cancer
$1,110,655Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2021 · HG
Combinational Immunotherapies to Amplify Vaccine Induced Immunity
$1,110,621Elizabeth Marion Jaffee · Johns Hopkins University · U19 · FY2008 · CA
Texas Medical Center Digestive Diseases Center
$1,110,570Hashem B El-Serag · Baylor College Of Medicine · P30 · FY2020 · DK
Strategies for Cancer Immunotherapy Clinical Trials
$1,107,978Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
$1,107,849Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Strategies for Cancer Immunotherapy Clinical Trials
$1,107,849Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Center for Applied Preclinical Research (CAPR)
$1,107,608Terry Van Dyke · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA
Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas
$1,107,123Anirban Maitra · University Of Tx Md Anderson Can Ctr · U01 · FY2018 · CA
Combinational Immunotherapies to Amplify Vaccine Induced Immunity
$1,106,675Elizabeth Marion Jaffee · Johns Hopkins University · U19 · FY2009 · CA
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer
$1,105,880Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
MEMBRANE TRAFFIC IN NORMAL AND TRANSFORMED CELLS
$1,105,691Yale University · P01 · FY2002 · CA
Studies of Tumor-Penetrating Microparticles for Pancreatic Cancer
$1,104,680Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
$1,104,636Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2022 · CA
UCLA Center for Excellence in Pancreatic Diseases
$1,104,454Vay Liang W. Go · University Of California Los Angeles · P01 · FY2010 · AT
DIRAS3 disrupts K-RAS clustering and signaling, enhancing autophagy and response to autophagy inhibition
$1,102,724Robert C Bast · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
MEMBRANE TRAFFIC IN NORMAL AND TRANSFORMED CELLS
$1,102,385Yale University · P01 · FY2001 · CA
Development of antibody-based cancer therapies
$1,100,911Mitchell Ho · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA